Basel Medical cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 5 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.55M | 0.32M | |||
| Share-based CompensationStock Comp. | -1.32M | -2.85M | -5.59M | ||
| Non-cash ItemsNon-Cash Items | 2.14M | 0.08M | |||
| Cash from OperationsCash from Ops. | -3.49M | ||||
| Depreciation, Depletion & Amortization | |||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.25M | 0.33M | 0.26M | ||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.02M | 0.02M | |||
| Change in Working Capital | |||||
| Change in ReceivablesChange Receivables | -1.57M | ||||
| Change in InventoryChange Inventory | -0.02M | ||||
| Change in Account PayablesChange Payables | -0.03M | -0.82M | -0.56M | ||
| Change in TaxesChange Taxes | -0.29M | -0.20M | |||
| Investing Activities | |||||
| Capital ExpendituresCapex | -0.01M | -0.02M | |||
| Cash from Investing ActivitiesCash from Investing | -0.01M | ||||
| Financing Activities | |||||
| Other financing activitiesOther financing | 1.17M | -0.30M | 0.02M | 0.03M | |
| Cash from Financing ActivitiesCash from Financing | -0.41M | ||||
| Additional items | |||||
| Change in Cash | -0.27M | 5.51M | -2.13M | ||
| Free Cash FlowFCF | 0.01M | -3.47M | |||
| Net Cash FlowNCF | -0.42M | -3.49M |